Literature DB >> 32112213

Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.

Dhaval Patel1, John E Phay2, Tina W F Yen3, Paxton V Dickson4, Tracy S Wang3, Roberto Garcia5, Anthony D Yang6, Lawrence T Kim7, Carmen C Solórzano8.   

Abstract

This is the second part of a two-part review on pheochromocytoma and paragangliomas (PPGLs). In this part, perioperative management, including preoperative preparation, intraoperative, and postoperative interventions are reviewed. Current data on outcomes following resection are presented, including outcomes after cortical-sparing adrenalectomy for bilateral adrenal disease. In addition, pathological features of malignancy, surveillance considerations, and the management of advanced disease are also discussed.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32112213     DOI: 10.1245/s10434-020-08221-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

Review 1.  Surgical treatment of adrenal tumors during pregnancy.

Authors:  Marisa A Bartz-Kurycki; Sophie Dream; Tracy S Wang
Journal:  Rev Endocr Metab Disord       Date:  2022-07-01       Impact factor: 9.306

2.  Clinical Predictors of Pseudohypoxia-Type Pheochromocytomas.

Authors:  J J Baechle; P Marincola Smith; C A Ortega; T S Wang; C C Solórzano; C M Kiernan
Journal:  Ann Surg Oncol       Date:  2022-03-01       Impact factor: 4.339

Review 3.  Pheochromocytoma and Paraganglioma: From Treatment to Follow-up.

Authors:  Nurcihan Aygun; Mehmet Uludag
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2020-12-11

Review 4.  Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas.

Authors:  Gustavo F C Fagundes; Madson Q Almeida
Journal:  J Endocr Soc       Date:  2022-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.